DRKS00019911招募中不适用
Prospective Clinical trial of BK polyomavirus (BKPyV) infections in adult kidney transplanted patients
niversitätsmedizin Rostock,Urologische Klinik und Poliklinik0 个研究点目标入组 50 人开始时间: 2019年11月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •age at least 18 year
- •- informed consent
- •- cadaveric kidney transplantation due to chronic kidney failure
排除标准
- •- multiple organ transplantations
研究者
相似试验
已完成
1 期
Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers.BK Virus NephropathyNCT05358106Memo Therapeutics AG40
招募中
不适用
New Therapeutic Approach Against BK Virus Infection Based on Monoclonal AntibodiesBK Virus InfectionNCT05264259University Hospital, Strasbourg, France100
已完成
早期 1 期
Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell LymphomaRefractory Mantle Cell LymphomaTransformed Recurrent Non-Hodgkin LymphomaNCT01719250Mayo Clinic7
进行中（未招募）
不适用
Phase II randomized trial of the Polo-like kinase 1 inhibitor BI 6727monotherapy versus investigator’s choice chemotherapy in ovariancancer patients resistant or refractory to platinum-based cytotoxictherapy - BI 6727 randomised phase II trial in ovarian cancerRecurrent ovarian cancer resistant or refractory to platinum compoundsEUCTR2009-015770-35-SEBoehringer Ingelheim AB118
进行中（未招募）
不适用
Phase II randomized trial of the Polo-like kinase 1 inhibitor BI 6727monotherapy versus investigator’s choice chemotherapy in ovariancancer patients resistant or refractory to platinum-based cytotoxictherapy - BI 6727 randomised phase II trial in ovarian cancerEUCTR2009-015770-35-FRBoehringer Ingelheim France100